FOIA to HHS OIG for Final Documents Produced From Investigation of Aduhelm Approval

FOIA request to the U.S. Department of Health and Human Services’ Office of Inspector General seeking any final documents produced by OIG during its investigation into the FDA’s approval of Aduhelm, and into interactions between Biogen and the FDA, leading up to the drug’s approval. HHS-22-0118